Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic
Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic
Legal battles over gene patents and uncooperative patent holders threaten the widespread implementation of personalized medicine
Microbiologist Marvin Whiteley chats about teaming up with chemist and bioengineer Jason Shear in order to build tiny houses for bacteria.
Follow the success story of a young boy who, with the help of the Care for Rare Foundation, underwent stem cell therapy for Wiskott-Aldrich Syndrome.
The Scientist covered some of the events that made this year's festival memorable
Is DNA damage an inevitable consequence of epigenetic reprogramming?
Paul Riley of University College London discusses his new research, published June 8th in Nature.
Researchers reveal several new viruses lurking in healthy hives